Key statistics
As of last trade Personalis Inc (04X:DUS) traded at 7.01, -26.88% below its 52-week high of 9.58, set on Nov 26, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 7.01 |
|---|---|
| High | 7.01 |
| Low | 7.01 |
| Bid | 7.01 |
| Offer | 7.43 |
| Previous close | 7.01 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 88.80m |
| Free float | 61.03m |
| P/E (TTM) | -- |
| Market cap | 729.08m USD |
| EPS (TTM) | -0.8761 USD |
Data delayed at least 15 minutes, as of Feb 16 2026 11:30 GMT.
More ▼
Press releases
- Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results
- Personalis Receives Medicare Coverage for NeXT Personal® in Lung Cancer Surveillance
- Personalis Announces New Publication Expanding Evidence for Ultrasensitive ctDNA Monitoring of Cancer Immunotherapy Response Across Solid Tumors
- Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™
- Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights
- Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors
- New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer
- Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference
More ▼
